This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Dear valued reader,
Title: Innovator Spotlight: Gregory C Leo
Introduction: Gregory C Leo, a talented inventor based in Lansdale, PA (US), has made groundbreaking contributions in the field of glucose absorption and excretion indicators through his patented methods using alpha-methylglucoside (AMG).
Latest Patents: Gregory C Leo holds a significant patent titled "Methods of using alpha-methylglucoside (AMG) as an indicator for glucose absorption and excretion." These innovative methods utilize AMG in vivo to assess glucose absorption from the gastrointestinal system or glucose excretion in the urine, enabling various applications in research and diagnostics.
Career Highlights: Gregory C Leo is associated with Janssen Pharmaceutica Nv, a leading pharmaceutical company known for its cutting-edge research and development initiatives. His collaboration with the company underscores his dedication to advancing medical science through inventive solutions.
Collaborations: Throughout his career, Gregory C Leo has worked closely with esteemed colleagues such as Keith T Demarest and James M Lenhard. Together, they have contributed to the collective knowledge in the field of pharmaceuticals and biochemistry, enriching the scientific community with their expertise.
Conclusion: Gregory C Leo's innovative methods using AMG as a glucose indicator showcase his commitment to driving advancements in healthcare and diagnostics. His contributions will continue to inspire advancements in the field, shaping the future of medical research.
Warm regards,
Diya at iDIYas
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile